1 result in 0.0066 seconds.
-
New Antibody-Drug Conjugate AMT-253 Demonstrates Dual Tumor Inhibition in Melanoma
The introduction of BRAF inhibitors and immune checkpoint inhibitors (ICIs) has substantially improved outcomes for melanoma patients. However, certain...